GABA changes with vigabatrin in the developing human brain

Epilepsia

Volumn 40, Issue 4, 1999, Pages 462-466

  Novotny Jr , Edward J ^a   Hyder, Fahmeed ^a   Shevell, Michael ^b   Rothman, Douglas L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Anticonvulsants; Children; Epilepsy; GABA; NMR; Nuclear magnetic resonance spectroscopy

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; VIGABATRIN;

4 AMINOBUTYRIC ACID RELEASE; AMINO ACID METABOLISM; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CASE REPORT; CHILD; DRUG EFFECT; FEMALE; GABAERGIC TRANSMISSION; HUMAN; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMITTER RELEASE; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0032913221     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00741.x     Document Type: Article

References (24)

1. Meldrum BS. GABAergic mechanisms in the pathogenesis and treatment of epilepsy. Br J Clin Pharmacol 1989;27(suppl 1):3S-11S.
2. Rothman DL, Behar KL, Hetherington HP, Shulman RG. Homo-nuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci U S A 1984;81:6330-4.
3. Rothman DL, Petroff OA, Behar KL, Mattson RH. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993;90:5662-6.
4. 1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA). Neurochem Res 1996:21:1031-41.
5. Mattson RH, Petroff O, Rothman D, Behar K. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy. Epilepsia 1994;35(suppl 5):S29-32.
6. Petroff OAC, Rothman DL, Behar KL, Mattson RH. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose. Neurology 1996;46:1459-63.
7. Petroff OA, Behar KL, Mattson RH, Rothman DL. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy. J Neurochem 1996;67:2399-404.
8. Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47:1567-71.
9. Uldall P, Alving J, Gram L, Hogenhaven H. Vigabatrin in childhood epilepsy: a 5-year follow-up study. Neuropediatrics 1995;26: 253-6.
10. Dodson WE, Bourgeois BF. Pharmacology and therapeutic aspects of antiepileptic drugs in pediatrics. J Child Neural 1994;9(suppl 2):1-7.
11. Novotny EJ. Overview: Role of NMR spectroscopy in epilepsy. Magn Reson Imaging 1995;13:1171-3.
12. Novotny E, Ashwal S, Shevell M. Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research [In Process Citation]. Pediatr Res 1998;44:1-10.
13. Petroff OA, Spencer DD, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989;39:1197-202.
14. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-37.
15. Hetherington HP, Mason GF, Pan JW, et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994;32:565-71.
16. Novotny EJ, Hyder F, Behar KL, Petroff OAC, Rothman DL. Alterations in cerebral GABA and glutamate in human epilepsy. Soc Neurosci Abstr 1997;43:816.
17. Halonen T, Pitkanen A, Saano V, Riekkinen PJ. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats. Epilepsia 1991;32:242-9.
18. Petroff OA, Rothman DL, Behar KL, Mattson RH. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia 1995:36:457-64.
19. Petroff OA, Rothman DL, Behar KL, Mattson RH. Low brain GABA level is associated with poor seizure control. Ann Neural 1996:40:908-11.
20. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996;39:95-9.
21. 31P metabolite differences in human cerebral gray and white matter. Magn Reson Med 1998:39:346-53.
22. Rothman DL, Hanstock CC, Petroff OA, Novotny EJ, Prichard JW, Shulman RG. Localized 1H NMR spectra of glutamate in the human brain. Magn Reson Med 1992;25:94-106.
23. 13C]glutamate turnover in human brain. Proc Natl Acad Sci U S A 1992;89:9603-6.
24. Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 1995;15:12-25.